Effect of Sodium-Glucose Co-transporter 2 Inhibitors on Bone Metabolism and Fracture Risk
Author:
Publisher
Frontiers Media SA
Subject
Pharmacology (medical),Pharmacology
Reference76 articles.
1. A mendelian randomization study of the effect of type-2 diabetes and glycemic traits on bone mineral density.;Ahmad;J. Bone Miner. Res.,2017
2. Efficacy and safety of empagliflozin added to existing antidiabetes treatment in patients with type 2 diabetes and chronic kidney disease: a randomised, double-blind, placebo-controlled trial.;Barnett;Lancet Diabetes Endocrinol.,2014
3. Evaluation of bone mineral density and bone biomarkers in patients with type 2 diabetes treated with canagliflozin.;Bilezikian;J. Clin. Endocrinol. Metab.,2016
4. Canagliflozin triggers the FGF23/1,25-dihydroxyvitamin D/PTH axis in healthy volunteers in a randomized crossover study.;Blau;JCI Insight,2018
5. Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin.;Bolinder;Diabetes Obes. Metab.,2014
Cited by 53 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Interrelationships among metabolic syndrome, bone-derived cytokines, and the most common metabolic syndrome-related diseases negatively affecting bone quality;Diabetology & Metabolic Syndrome;2024-09-06
2. SGLT2 inhibitors: a novel therapy for cognitive impairment via multifaceted effects on the nervous system;Translational Neurodegeneration;2024-08-09
3. SGLT2 inhibitors and nephrolithiasis risk: a meta-analysis;Nephrology Dialysis Transplantation;2024-08-07
4. Risk of limb amputation and bone fractures with sodium glucose cotransporter-2 inhibitors: a network meta-analysis and meta-regression;Expert Opinion on Drug Safety;2024-07-08
5. Falls in hospitalized older adults and the use of fall risk-increasing drugs and anticholinergic medications in Colombia: a case‒control study;Frontiers in Pharmacology;2024-07-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3